Concentration of plasminogen activators and inhibitor in the human endometrium at different phases of the menstrual cycle

J Reprod Fertil. 1992 Nov;96(2):407-13. doi: 10.1530/jrf.0.0960407.

Abstract

The concentrations of tissue plasminogen activator (t-PA), urokinase plasminogen activator (u-PA) and plasminogen activator inhibitor (PAI-1) have been determined in endometrial curettings obtained from 46 subfertile women during proliferative, early or late secretory phases of the menstrual cycle. t-PA activity and antigen concentrations was significantly higher (P < 0.001) in late secretory endometrium than in proliferative or early secretory endometrium. Higher concentrations of PAI-1 antigen (P < 0.05) were also noted in late secretory phase than in proliferative and early secretory endometrium. However, u-PA concentration was not significantly different and no PAI activity could be demonstrated in the menstrual phases studied. Zymography studies confirmed the presence of both t-PA and u-PA in the endometrium. Ovarian hormonal patterns may therefore influence the activity of plasminogen activators especially of t-PA in the endometrium during various phases of the menstrual cycle.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Animals
  • Electrophoresis, Polyacrylamide Gel
  • Endometrium / metabolism*
  • Female
  • Follicular Phase / metabolism
  • Humans
  • Infertility, Female / metabolism*
  • Luteal Phase / metabolism
  • Male
  • Menstrual Cycle / metabolism*
  • Plasminogen Activator Inhibitor 1 / biosynthesis*
  • Plasminogen Activators / biosynthesis*
  • Rabbits
  • Tissue Plasminogen Activator / biosynthesis
  • Urokinase-Type Plasminogen Activator / biosynthesis

Substances

  • Plasminogen Activator Inhibitor 1
  • Plasminogen Activators
  • Tissue Plasminogen Activator
  • Urokinase-Type Plasminogen Activator